Cumulative Delivery Rates After ICSI Treatment Cycles with Freshly Retrieved Testicular Sperm: a 7-year Follow-up Study
Overview
Authors
Affiliations
Background: The purpose of this study was to assess cumulative delivery rates in patients with non-obstructive or obstructive azoospermia following treatment by testicular sperm extraction (TESE)-ICSI.
Methods: A cohort follow-up study was conducted. Between January 1994 and December 2000, 364 couples with obstructive azoospermia underwent a total of 609 fresh TESE-ICSI treatment cycles. In addition, 303 fresh TESE-ICSI treatment cycles were performed in 235 couples for non-obstructive azoospermia. This study included only patients in whom sperm was recovered. In the non-obstructive group, only patients with maturation arrest, atrophic sclerosis and germ cell aplasia were included. The main outcome measure was a delivery beyond 25 weeks gestation.
Results: In patients with obstructive azoospermia, the crude delivery rate after three cycles was 35% while the expected cumulative delivery rate was 48% [95% confidence interval (CI), 41-55]. On the other hand, in patients with non-obstructive azoospermia, the crude cumulative delivery rate after three treatment cycles was 17% while the expected delivery rate was 31% (95% CI, 15-46). A high dropout rate in couples with both non-obstructive and obstructive azoospermia was observed (75 and 50% respectively, after the first cycle).
Conclusion: This study shows that there is a value in performing several TESE-ICSI attempts in patients with obstructive and non-obstructive azoospermia. The estimates of the non-obstructive group beginning from the third cycle are less reliable due to fewer patients. However, overall, the obstructive group performed better than the non-obstructive group.
Severe male factor in fertilization: definition, prevalence, and treatment. An update.
Mazzilli R, Vaiarelli A, Dovere L, Cimadomo D, Ubaldi N, Ferrero S Asian J Androl. 2021; 24(2):125-134.
PMID: 34259196 PMC: 8887096. DOI: 10.4103/aja.aja_53_21.
Reproductive Chances of Men with Azoospermia Due to Spermatogenic Dysfunction.
Kang C, Punjani N, Schlegel P J Clin Med. 2021; 10(7).
PMID: 33807489 PMC: 8036343. DOI: 10.3390/jcm10071400.
Factors Influencing Success Rate of Intracytoplasmic Sperm Injection with Azoospermic Male Patients.
Rehnitz J, Rosner S, Harsch J, Dietrich J, Bruckner T, Capp E Geburtshilfe Frauenheilkd. 2020; 80(7):713-722.
PMID: 32675833 PMC: 7360402. DOI: 10.1055/a-1180-9094.
DAndrea S, Giordano A, Carducci S, Sacchetti L, Necozione S, Costanzo M J Endocrinol Invest. 2015; 38(7):785-90.
PMID: 25740066 DOI: 10.1007/s40618-015-0259-x.
Gangrade B Clinics (Sao Paulo). 2013; 68 Suppl 1:131-40.
PMID: 23503963 PMC: 3583152. DOI: 10.6061/clinics/2013(sup01)15.